
Avo is the no code platform used by healthcare organizations to improve care and operational outcomes in a way clinicians love. Our integrated AI platform simplifies everyday clinical tasks like documentation, charting, discharge planning, ordering and more. Avo supports every member of the care team by effortlessly incorporating guidelines, protocols, and patient data into the workflow and transforming it into actionable tools. At Avo, we believe in standardizing care with love, not alerts. Visit avomd.com to learn more.

Avo is the no code platform used by healthcare organizations to improve care and operational outcomes in a way clinicians love. Our integrated AI platform simplifies everyday clinical tasks like documentation, charting, discharge planning, ordering and more. Avo supports every member of the care team by effortlessly incorporating guidelines, protocols, and patient data into the workflow and transforming it into actionable tools. At Avo, we believe in standardizing care with love, not alerts. Visit avomd.com to learn more.
What: EHR-integrated, no-code clinician support platform that embeds guidelines into workflow and uses AI to simplify documentation, charting, discharge planning, ordering, and other clinical tasks.
Key products: AI Scribe, Chart Assist, Ask Avo (EHR-integrated AI consult tool; launched Sep 30, 2024).
Headquarters: New York
Employees: 38
Funding: $11.1M total reported (two seed rounds); $5M seed in June 2023 led by AlleyCorp.
Integrations & compliance: SMART-on-FHIR, MEDITECH, athenahealth Marketplace; SOC 2 Type II compliance.
Clinician burnout and the difficulty of applying clinical pathways/guidelines within EHR workflows; need to standardize care and automate routine clinical tasks.
Healthcare
$5M
Dealroom reports total funding of $11.1M across two seed rounds; $5M seed in June 2023 led by AlleyCorp.
$3M
Avo announced a $3M funding round with participating investors named as Dunamu, Mirae Asset Global Investments, SpringCamp, FuturePlay, and World Trade Ventures; previous investors cited include 500 Startups, StartUp Health, and Columbia University.
“Backed by AlleyCorp (lead on June 2023 seed) and investors including StartUp Health, Mirae Asset, Dunamu & Partners, Mount Sinai Innovation Partners, and others.”
| Company |
|---|